{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT03974113: Phase 3 Interventional Active, not recruiting Hemophilia
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04544956: Phase 2 Interventional Completed Hepatitis B
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01065935: Phase 2 Interventional Completed Respiratory Syncytial Virus Infections
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00306904: Phase 2 Interventional Completed Diabetic Macular Edema
(2006)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00042081: Phase 3 Interventional Completed Coronary Artery Disease
(2002)
Source URL:
Class:
NUCLEIC ACID
Status:
Designated
Source:
FDA ORPHAN DRUG:173903
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
BLA125428
(2017)
Source URL:
First approved in 2017
Source:
BLA125428
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2016)
Source:
NDA208114
(2016)
Source URL:
First approved in 2016
Source:
NDA208114
Source URL:
Class:
POLYMER
